Avinger announces presentations by key opinion leaders at new cardiovascular horizons annual conference

Redwood city, ca / accesswire / june 7, 2021 / avinger, inc. (nasdaq:avgr), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of peripheral artery disease (pad), today announced two podium presentations featuring the company's lumivascular technology at the new cardiovascular horizons (ncvh) annual conference, which took place june 1 through june 4 in new orleans. key opinion leaders in the fields of interventional cardiology and endovascular interventions highlighted avinger's lumivascular technology in the following sessions: dr. jon george, an interventional cardiologist and endovascular medicine specialist at pennsylvania hospital, university of pennsylvania health system in philadelphia, included avinger's proprietary oct-guided platform in his session, "are intravascular ultrasound and oct being utilized enough in peripheral interventions?
AVGR Ratings Summary
AVGR Quant Ranking